Proteomic analysis of two Trypanosoma cruzi zymodeme 3 strains

Experimental Parasitology

Volumn 126, Issue 4, 2010, Pages 540-551

  Kikuchi, Simone A ^a   Sodré, Cátia L ^a   Kalume, Dário E ^a   Elias, Camila G R ^b   Santos, André L S ^b   de Nazaré Soeiro, Maria ^a   Meuser, Marcus ^a   Chapeaurouge, Alex ^a   Perales, Jonas ^a   Fernandes, Octavio ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Infectivity; Proteome; Trypanosoma cruzi; Zymodeme 3

Indexed keywords

MICROORGANISM PROTEIN; CRUZIPAIN; CYSTEINE PROTEINASE; PROTEOME; PROTOZOAL PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINEAGE; CELL STRAIN; CELL STRAIN RAW 264.7; CHAGAS DISEASE; CONTROLLED STUDY; HEP 2 CELL; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; INSECT CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; STRAIN DIFFERENCE; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; VERO CELL; AEDES; ANIMAL; CELL LINE; CHEMISTRY; CHLOROCEBUS AETHIOPS; CLASSIFICATION; DISEASE CARRIER; GROWTH, DEVELOPMENT AND AGING; OPOSSUM; PARASITOLOGY; TRIATOMINAE; TWO DIMENSIONAL GEL ELECTROPHORESIS; VERO CELL LINE;

AEDES; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEASES; DIDELPHIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; INSECT VECTORS; PROTEOME; PROTEOMICS; PROTOZOAN PROTEINS; TRIATOMINAE; TRYPANOSOMA CRUZI; VERO CELLS;

HEXAPODA; TRYPANOSOMA CRUZI;

EID: 84755160970     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.06.005     Document Type: Article

References (64)

1. Alonso G.D., Pereira C.A., Remedi M.S., Paveto M.C., Cochella L., Ivaldi M.S., Gerez de Burgos N.M., Torres H.N., Flawia M.M. Arginine kinase of the flagellate protozoa Trypanosoma cruzi. Regulation of its expression and catalytic activity. FEBS Letter 2001, 498:22-25.
2. Andrade H.M., Murta S.M., Chapeaurouge A., Perales J., Nirde P., Romanha A.J. Proteomic analysis of Trypanosoma cruzi resistance to Benznidazole. Journal of Proteome Research 2008, 7:2357-2367.
3. Aparicio I.M., Scharfstein J., Lima A.P. A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. Infection and Immunity 2004, 72:5892-5902.
4. Aslund L., Henriksson J., Campetella O., Frasch A.C., Pettersson U., Cazzulo J.J. The C-terminal extension of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi. Molecular and Biochemical Parasitology 1991, 45:345-347.
5. Atwood J.A., Weatherly D.B., Minning T.A., Bundy B., Cavola C., Opperdoes F.R., Orlando R., Tarleton R.L. The Trypanosoma cruzi proteome. Science 2005, 309:473-476.
6. Bonaldo M.C., d'Escoffier L.N., Salles J.M., Goldenberg S. Characterization and expression of proteases during Trypanosoma cruzi metacyclogenesis. Experimental Parasitology 1991, 73:44-51.
7. Brandão A., Fernandes O. Trypanosoma cruzi: mutations in the 3' untranslated region of calmodulin gene are specific for lineages T. cruzi I, T. cruzi II, and the Zymodeme III isolates. Experimental Parasitology 2006, 112:247-252.
8. Brener Z., Chiari E. Morphological variations observed in different strains of Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo 1963, 19:220-224.
9. Burleigh B.A., Woolsey A.M. Cell signalling and Trypanosoma cruzi invasion. Cellular Microbiology 2002, 4:701-711.
10. Cardoni R.L., Antunez M.I., Morales C., Nantes I.R. Release of reactive oxygen species by phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. The American Journal of Tropical Medicine and Hygiene 1997, 56:329-334.
11. Castro H., Tomas A.M. Peroxidases of trypanosomatids. Antioxidants and Redox Signaling 2008, 10:1593-1606.
12. Cazzulo J.J. Proteinases of Trypanosoma cruzi: potential targets for the chemotherapy of Chagas disease. Current Topics in Medicinal Chemistry 2002, 2:1261-1271.
13. Contreras V.T., Araujo-Jorge T.C., Bonaldo M.C., Thomaz N., Barbosa H.S., Meirelles Mde N., Goldenberg S. Biological aspects of the Dm 28c clone of Trypanosoma cruzi after metacyclogenesis in chemically defined media. Memorias do Instituto Oswaldo Cruz 1988, 83:123-133.
14. Coura J.R., Junqueira A.C., Fernandes O., Valente S.A., Miles M.A. Emerging Chagas disease in Amazonian Brazil. Trends in Parasitology 2002, 18:171-176.
15. de Freitas J.M., Augusto-Pinto L., Pimenta J.R., Bastos-Rodrigues L., Goncalves V.F., Teixeira S.M., Chiari E., Junqueira A.C., Fernandes O., Macedo A.M., Machado C.R., Pena S.D. Ancestral genomes, sex, and the population structure of Trypanosoma cruzi. PLoS Pathogens 2006, 2:e24.
16. Del Nery E., Juliano M.A., Lima A.P., Scharfstein J., Juliano L. Kininogenase activity by the major cysteinyl proteinase (cruzipain) from Trypanosoma cruzi. The Journal of Biological Chemistry 1997, 272:25713-25718.
17. dos Santos A.L., Abreu C.M., Alviano C.S., de Araujo Soares R.M. Activation of the glycosylphosphatidylinositol-anchored membrane proteinase upon release from Herpetomonas samuelpessoai by phospholipase C. Current Microbiology 2002, 45:293-298.
18. Emanuelsson O., Brunak S., von Heijne G., Nielsen H. Locating proteins in the cell using TargetP, SignalP and related tools. Nature Protocols 2007, 2:953-971.
19. Engel J.C., Doyle P.S., Palmer J., Hsieh I., Bainton D.F., McKerrow J.H. Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi. Journal of Cell Science 1998, 111(Pt 5):597-606.
20. Ferella M., Nilsson D., Darban H., Rodrigues C., Bontempi E.J., Docampo R., Andersson B. Proteomics in Trypanosoma cruzi - localization of novel proteins to various organelles. Proteomics 2008, 8:2735-2749.
21. Fernandes O., Souto R.P., Castro J.A., Pereira J.B., Fernandes N.C., Junqueira A.C., Naiff R.D., Barrett T.V., Degrave W., Zingales B., Campbell D.A., Coura J.R. Brazilian isolates of Trypanosoma cruzi from humans and triatomines classified into two lineages using mini-exon and ribosomal RNA sequences. The American Journal of Tropical Medicine and Hygiene 1998, 58:807-811.
22. Gillmor S.A., Craik C.S., Fletterick R.J. Structural determinants of specificity in the cysteine protease cruzain. Protein Science 1997, 6:1603-1611.
23. Haile S., Papadopoulou B. Developmental regulation of gene expression in trypanosomatid parasitic protozoa. Current Opinion in Microbiology 2007, 10:569-577.
24. Harth G., Andrews N., Mills A.A., Engel J.C., Smith R., McKerrow J.H. Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi. Molecular and Biochemical Parasitology 1993, 58:17-24.
25. Heussen C., Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Analytical Biochemistry 1980, 102:196-202.
26. Igarashi A. Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses. The Journal of General Virology 1978, 40:531-544.
27. Kalume D.E., Peri S., Reddy R., Zhong J., Okulate M., Kumar N., Pandey A. Genome annotation of Anopheles gambiae using mass spectrometry-derived data. BMC Genomics 2005, 6:128.
28. Keiko Toma H., Penna Ceravolo I., Guerra H.L., Steindel M., Romanha A.J. Trypanosoma cruzi: parasitaemia produced in mice does not seem to be related to in vitro parasite-cell interaction. International Journal for Parasitology 2000, 30:593-597.
29. Larsen M.R., Trelle M.B., Thingholm T.E., Jensen O.N. Analysis of posttranslational modifications of proteins by tandem mass spectrometry. BioTechniques 2006, 40:790-798.
30. Lima A.P., dos Reis F.C., Serveau C., Lalmanach G., Juliano L., Menard R., Vernet T., Thomas D.Y., Storer A.C., Scharfstein J. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors. Molecular and Biochemical Parasitology 2001, 114:41-52.
31. Lima A.P., Almeida P.C., Tersariol I.L., Schmitz V., Schmaier A.H., Juliano L., Hirata I.Y., Muller-Esterl W., Chagas J.R., Scharfstein J. Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain. The Journal of Biological Chemistry 2002, 277:5875-5881.
32. McGrath M.E., Eakin A.E., Engel J.C., McKerrow J.H., Craik C.S., Fletterick R.J. The crystal structure of cruzain: a therapeutic target for Chagas' disease. Journal of Molecular Biology 1995, 247:251-259.
33. Meirelles M.N., Juliano L., Carmona E., Silva S.G., Costa E.M., Murta A.C., Scharfstein J. Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Molecular and Biochemical Parasitology 1992, 52:175-184.
34. Meldal M., Svendsen I.B., Juliano L., Juliano M.A., Nery E.D., Scharfstein J. Inhibition of cruzipain visualized in a fluorescence quenched solid-phase inhibitor library assay. d-amino acid inhibitors for cruzipain, cathepsin B and cathepsin L. Journal of Peptide Science 1998, 4:83-91.
35. Mendonça M.B., Nehme N.S., Santos S.S., Cupolillo E., Vargas N., Junqueira A., Naiff R.D., Barrett T.V., Coura J.R., Zingales B., Fernandes O. Two main clusters within Trypanosoma cruzi zymodeme 3 are defined by distinct regions of the ribosomal RNA cistron. Parasitology 2002, 124:177-184.
36. Miles M.A., Yeo M., Gaunt M. Genetic diversity of Trypanosoma cruzi and the epidemiology of Chagas disease. Molecular Mechanisms of Pathogenesis in Chagas' Disease 2003, 1-15. Springer, Landes Bioscience, Austin, TX, USA. J.M. Kelly (Ed.).
37. Miles M.A., Toye P.J., Oswald S.C., Godfrey D.G. The identification by isoenzyme patterns of two distinct strain-groups of Trypanosoma cruzi, circulating independently in a rural area of Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 1977, 71:217-225.
38. Miles M.A., Souza A., Povoa M., Shaw J.J., Lainson R., Toye P.J. Isozymic heterogeneity of Trypanosoma cruzi in the first autochthonous patients with Chagas' disease in Amazonian Brazil. Nature 1978, 272:819-821.
39. Paba J., Ricart C.A., Fontes W., Santana J.M., Teixeira A.R., Marchese J., Williamson B., Hunt T., Karger B.L., Sousa M.V. Proteomic analysis of Trypanosoma cruzi developmental stages using isotope-coded affinity tag reagents. Journal of Proteome Research 2004, 3:517-524.
40. Paba J., Santana J.M., Teixeira A.R., Fontes W., Sousa M.V., Ricart C.A. Proteomic analysis of the human pathogen Trypanosoma cruzi. Proteomics 2004, 4:1052-1059.
41. Parodi-Talice A., Duran R., Arrambide N., Prieto V., Pineyro M.D., Pritsch O., Cayota A., Cervenansky C., Robello C. Proteome analysis of the causative agent of Chagas disease: Trypanosoma cruzi. International Journal for Parasitology 2004, 34:881-886.
42. Pedroso A., Cupolillo E., Zingales B. Trypanosoma cruzi: exploring the nuclear genome of zymodeme 3 stocks by chromosome size polymorphism. Experimental Parasitology 2007, 116:71-76.
43. Pereira C.A., Alonso G.D., Paveto M.C., Flawia M.M., Torres H.N. l-arginine uptake and l-phosphoarginine synthesis in Trypanosoma cruzi. The Journal of Eukaryotic Microbiology 1999, 46:566-570.
44. Pereira C.A., Alonso G.D., Paveto M.C., Iribarren A., Cabanas M.L., Torres H.N., Flawia M.M. Trypanosoma cruzi arginine kinase characterization and cloning. A novel energetic pathway in protozoan parasites. The Journal of Biological Chemistry 2000, 275:1495-1501.
45. Pereira C.A., Alonso G.D., Torres H.N., Flawia M.M. Arginine kinase: a common feature for management of energy reserves in African and American flagellated trypanosomatids. The Journal of Eukaryotic Microbiology 2002, 49:82-85.
46. Piñeyro M.D., Parodi-Talice A., Arcari T., Robello C. Peroxiredoxins from Trypanosoma cruzi: virulence factors and drug targets for treatment of Chagas disease?. Gene 2008, 408:45-50.
47. Reguera R.M., Balana-Fouce R., Perez-Pertejo Y., Fernandez F.J., Garcia-Estrada C., Cubria J.C., Ordonez C., Ordonez D. Cloning expression and characterization of methionine adenosyltransferase in Leishmania infantum promastigotes. The Journal of Biological Chemistry 2002, 277:3158-3167.
48. Sajid M., McKerrow J.H. Cysteine proteases of parasitic organisms. Molecular and Biochemical Parasitology 2002, 120:1-21.
49. Santos A.L., Branquinha M.H., D'Avila-Levy C.M. The ubiquitous gp63-like metalloprotease from lower trypanosomatids: in the search for a function. Anais da Academia Brasileira de Ciências 2006, 78:687-714.
50. Scharfstein J., Lima A.P. Roles of naturally occurring protease inhibitors in the modulation of host cell signaling and cellular invasion by Trypanosoma cruzi. Sub-Cellular Biochemistry 2008, 47:140-154.
51. Schenkman S., Jiang M.S., Hart G.W., Nussenzweig V. A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells. Cell 1991, 65:1117-1125.
52. Serveau C., Lalmanach G., Juliano M.A., Scharfstein J., Juliano L., Gauthier F. Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors. The Biochemical Journal 1996, 313(Pt 3):951-956.
53. Serveau C., Lalmanach G., Hirata I., Scharfstein J., Juliano M.A., Gauthier F. Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases. European Journal of Biochemistry 1999, 259:275-280.
54. Silber A.M., Colli W., Ulrich H., Alves M.J., Pereira C.A. Amino acid metabolic routes in Trypanosoma cruzi: possible therapeutic targets against Chagas' disease. Current Drug Targets: Infectious Disorders 2005, 5:53-64.
55. Sodre C.L., Chapeaurouge A.D., Kalume D.E., de Mendonca Lima L., Perales J., Fernandes O. Proteomic map of Trypanosoma cruzi CL Brener: the reference strain of the genome project. Archives of Microbiology 2009, 191:177-184.
56. Souto R.P., Fernandes O., Macedo A.M., Campbell D.A., Zingales B. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Molecular and Biochemical Parasitology 1996, 83:141-152.
57. Tomas A.M., Kelly J.M. Stage-regulated expression of cruzipain, the major cysteine protease of Trypanosoma cruzi is independent of the level of RNA1. Molecular and Biochemical Parasitology 1996, 76:91-103.
58. WHO, 2002. Expert Committee on the Control of Chagas Disease. Second Report. World Health Organization, Geneva.
59. Wilkinson S.R., Temperton N.J., Mondragon A., Kelly J.M. Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi. The Journal of Biological Chemistry 2000, 275:8220-8225.
60. Yakubu M.A., Majumder S., Kierszenbaum F. Inhibition of S-adenosyl-l-methionine (AdoMet) decarboxylase by the decarboxylated AdoMet analog 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine (MDL 73811) decreases the capacities of Trypanosoma cruzi to infect and multiply within a mammalian host cell. The Journal of Parasitology 1993, 79:525-532.
61. Yoshida N. Molecular basis of mammalian cell invasion by Trypanosoma cruzi. Anais da Academia Brasileira de Ciências 2006, 78:87-111.
62. Yoshida N., Cortez M. Trypanosoma cruzi: parasite and host cell signaling during the invasion process. Sub-Cellular Biochemistry 2008, 47:82-91.
63. Zingales B., Pereira M.E., Oliveira R.P., Almeida K.A., Umezawa E.S., Souto R.P., Vargas N., Cano M.I., da Silveira J.F., Nehme N.S., Morel C.M., Brener Z., Macedo A. Trypanosoma cruzi genome project: biological characteristics and molecular typing of clone CL Brener. Acta Tropica 1997, 68:159-173.
64. Zingales B., Andrade S.G., Briones M.R., Campbell D.A., Chiari E., Fernandes O., Guhl F., Lages-Silva E., Macedo A.M., Machado C.R., Miles M.A., Romanha A.J., Sturm N.R., Tibayrenc M., Schijman A.G. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Memorias do Instituto Oswaldo Cruz 2009, 104:1051-1054.